Author information:
(1)From the Barcelonaβeta Brain Research Center (BBRC) (M.M.-A., M.S., G.O., 
G.S., C.F., J.D.G., N.V.-T., E.M.A.-U., O.G.-R., A.S.-V., G.S.-B., J.M.G.-d-E., 
C.M., K.F., J.L.M., M.S.-C.), Pasqual Maragall Foundation; IMIM (Hospital del 
Mar Medical Research Institute) (M.M.-A., M.S., G.O., G.S., C.F., J.D.G., 
E.M.A.-U., O.G.-R., A.S.-V., G.S.-B., J.M.G.-d-E., C.M., M.S.-C.), Barcelona; 
Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento 
Saludable (CIBERFES) (M.M.-A., G.O., E.M.A.-U., O.G.-R., G.S.-B., C.M., K.F., 
M.S.-C.), Madrid; Universitat Pompeu Fabra (M.M.-A., M.S.), Barcelona, Spain; 
Department of Psychiatry and Neurochemistry (A.B., N.J.A., H.K., H.Z., K.B.), 
Institute of Neuroscience and Physiology, University of Gothenburg; Clinical 
Neurochemistry Laboratory (A.B., H.K., H.Z., K.B.), Sahlgrenska University 
Hospital, Mölndal; Wallenberg Centre for Molecular and Translational Medicine 
(A.B., N.J.A., H.K.), Department of Psychiatry and Neurochemistry, Institute of 
Neuroscience and Physiology, the Sahlgrenska Academy at the University of 
Gothenburg, Sweden; King's College London (N.J.A.), Institute of Psychiatry, 
Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute; NIHR 
Biomedical Research Centre for Mental Health & Biomedical Research Unit for 
Dementia at South London & Maudsley NHS Foundation (N.J.A.), London, UK; Centro 
de Investigación Biomédica en Red de Bioingeniería (C.F., J.D.G., A.N.-B., 
A.P.), Biomateriales y Nanomedicina (CIBER-BBN), Madrid; Centre for Genomic 
Regulation (CRG) (N.V.-T.), Barcelona Institute for Science and Technology; 
Department of Clinical Genetics (N.V.-T.), Erasmus MC, University Medical Center 
Rotterdam, the Netherlands; Servei de Neurologia (O.G.-R., M.S.-C.), Hospital 
del Mar; Servei de Medicina Nuclear (A.N.-B., A.P.), Hospital Clínic, Barcelona, 
Spain; Roche Diagnostics GmbH (G.K.), Penzberg, Germany; Roche Diagnostics 
International Ltd (I.S.), Rotkreuz, Switzerland; UK Dementia Research Institute 
at UCL (H.Z.), London; Department of Neurodegenerative Disease (H.Z.), UCL Queen 
Square Institute of Neurology, London, UK; and H. Lundbeck A/S (J.L.M.), 
Copenhagen, Denmark.
(2)From the Barcelonaβeta Brain Research Center (BBRC) (M.M.-A., M.S., G.O., 
G.S., C.F., J.D.G., N.V.-T., E.M.A.-U., O.G.-R., A.S.-V., G.S.-B., J.M.G.-d-E., 
C.M., K.F., J.L.M., M.S.-C.), Pasqual Maragall Foundation; IMIM (Hospital del 
Mar Medical Research Institute) (M.M.-A., M.S., G.O., G.S., C.F., J.D.G., 
E.M.A.-U., O.G.-R., A.S.-V., G.S.-B., J.M.G.-d-E., C.M., M.S.-C.), Barcelona; 
Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento 
Saludable (CIBERFES) (M.M.-A., G.O., E.M.A.-U., O.G.-R., G.S.-B., C.M., K.F., 
M.S.-C.), Madrid; Universitat Pompeu Fabra (M.M.-A., M.S.), Barcelona, Spain; 
Department of Psychiatry and Neurochemistry (A.B., N.J.A., H.K., H.Z., K.B.), 
Institute of Neuroscience and Physiology, University of Gothenburg; Clinical 
Neurochemistry Laboratory (A.B., H.K., H.Z., K.B.), Sahlgrenska University 
Hospital, Mölndal; Wallenberg Centre for Molecular and Translational Medicine 
(A.B., N.J.A., H.K.), Department of Psychiatry and Neurochemistry, Institute of 
Neuroscience and Physiology, the Sahlgrenska Academy at the University of 
Gothenburg, Sweden; King's College London (N.J.A.), Institute of Psychiatry, 
Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute; NIHR 
Biomedical Research Centre for Mental Health & Biomedical Research Unit for 
Dementia at South London & Maudsley NHS Foundation (N.J.A.), London, UK; Centro 
de Investigación Biomédica en Red de Bioingeniería (C.F., J.D.G., A.N.-B., 
A.P.), Biomateriales y Nanomedicina (CIBER-BBN), Madrid; Centre for Genomic 
Regulation (CRG) (N.V.-T.), Barcelona Institute for Science and Technology; 
Department of Clinical Genetics (N.V.-T.), Erasmus MC, University Medical Center 
Rotterdam, the Netherlands; Servei de Neurologia (O.G.-R., M.S.-C.), Hospital 
del Mar; Servei de Medicina Nuclear (A.N.-B., A.P.), Hospital Clínic, Barcelona, 
Spain; Roche Diagnostics GmbH (G.K.), Penzberg, Germany; Roche Diagnostics 
International Ltd (I.S.), Rotkreuz, Switzerland; UK Dementia Research Institute 
at UCL (H.Z.), London; Department of Neurodegenerative Disease (H.Z.), UCL Queen 
Square Institute of Neurology, London, UK; and H. Lundbeck A/S (J.L.M.), 
Copenhagen, Denmark. msuarez@barcelonabeta.org.